A new study led by NYU Langone Health researchers found that cancer cells are better able to resist treatments when they have ...
Arteriovenous malformations, a hallmark of hereditary hemorrhagic telangiectasia, may be driven by endothelial cell-cycle acceleration via CDK6, suggesting potential for repurposing CDK6 inhibitors.
2don MSN
Cancer cells are better able to resist treatments when they have an abnormal number of chromosomes
A new study led by NYU Langone Health researchers has found that cancer cells are better able to resist treatments when they ...
New resistance mechanism: Aneuploid cancer cells have 50–60% less PARP1, helping them survive treatment-induced oxidative stress. How it works: Chromosome errors trigger lysosomal stress, activating ...
Different types of cell division failure shape whether duplicated cells survive, remain stable, or lead to cancer.
Working with human breast and lung cells, Johns Hopkins Medicine scientists say they have charted a molecular pathway that can lure cells down a hazardous path of duplicating their genome too many ...
A hidden clue may explain why some mutated cells become cancerous and others don’t: how fast they divide. A new study from researchers at Sinai Health in Toronto reveals that the total time it takes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results